Brief: Strides Pharma Science Gets US FDA Approval For Gabapentin Tablets Usp, 600 Mg And 800 Mg
05/03/2024 07:31
March 5 (Reuters) - Strides Pharma Science Ltd
SRID.NS :
* RECEIVES USFDA APPROVAL FOR GABAPENTIN TABLETS USP, 600 MG
AND
800 MG
Source text for Eikon: ID:
Further company coverage: SRID.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Strides Pharma Science
See all newsIndia's Strides Pharma jumps on successful closure of USFDA inspection at Bengaluru facility
Brief: Strides Pharma Science Receives USFDA EIR For Flagship Facility In Bengaluru
Brief: Strides Pharma Science Receives US FDA Establishment Inspection Report For Bengaluru Facility
Brief: Strides Pharma Science June-Quarter Consol Net Profit 1.57 Billion Rupees
Brief: Strides Pharma Science March-Quarter Consol Net Profit 1.27 Billion Rupees